Staying on TRK: Addressing Clinical Challenges and Improving Outcomes in NTRK Fusion–Positive Cancers

Download All
Hear from the experts on how the latest clinical data inform the treatment of patients with NTRK fusions. Review their insights in an on-demand webcast adapted from a live webinar along with downloadable slidesets.
George D. Demetri, MD
Program Director
George D. Demetri, MD
Alexander Drilon, MD
Theodore Laetsch, MD

Downlaodable Slidesets

Download these expert-selected slides on testing for TRK fusions in your patients with cancer.

George D. Demetri, MD Released: June 11, 2021

Download these expert-selected slides on treating patients with NTRK-positive tumors with TRK inhibitors.

Alexander Drilon, MD Released: June 11, 2021

Download these expert-selected slides on overcoming acquired resistance with TRK inhibitors.

Theodore Laetsch, MD Released: June 11, 2021

Download these expert-selected slides with the latest information on testing for TRK fusions and treating your patients with NTRK fusion-positive cancers.

George D. Demetri, MD Alexander Drilon, MD Theodore Laetsch, MD Released: June 16, 2021

On-Demand Webcast

In this on-demand webcast from a live symposium, expert faculty discuss the latest guidance and clinical data in the diagnosis and treatment of patients with NTRK fusion‑positive cancers.

George D. Demetri, MD
Program Director
Alexander Drilon, MD Theodore Laetsch, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: July 7, 2021 Expired: July 6, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue